Short-term outcomes of combined therapy with sirolimus and interferon-alpha 2b for advanced hepatic epithelioid hemangioendothelioma.

Xiaolei LiuRuiquan ZhouLiguo LiuShuang SiShiwei YangDongdong HanHaidong Tan

Published in: Therapeutic advances in medical oncology (2024)

Sirolimus and IFN-a 2b may have synergistic effects in the treatment of hepatic EHE. SI therapy is a safe and effective treatment for hepatic EHE patients with good ECOG performance status.

Keyphrases

dendritic cells
immune response
stem cells
drug delivery
bone marrow
cell therapy
combination therapy
replacement therapy
room temperature